Table 3. Clinical features of psoriatic arthritis patients (n=51).
| n | % | Mean±SD | |
| Disease duration | |||
| Psoriasis | 17.6±7.3 | ||
| Psoriatic arthritis | 8.7±11.4 | ||
| Disease pattern | |||
| Peripheral disease only | 32 | 62.7 | |
| Axial disease | 19 | 32.8 | |
| Disease activity | |||
| Minimal disease activity | 36 | 70.6 | |
| Active disease | 15 | 29.4 | |
| Current treatment | |||
| NSAIDs only | 6 | 11.8 | |
| cDMARDS | 29 | 56.8 | |
| bDMARDs | 12 | 23.5 | |
| cDMARDs + bDMARDs | 4 | 7.8 | |
| SD: Standard deviation; bDMARDs: Biologic disease-modifying antirheumatic drugs; cDMARDs: Conventional disease-modifying antirheumatic drugs; NSAIDs: Nonsteroidal anti-inflammatory drugs. | |||